The first GLP-1 receptor agonist approved for obesity was liraglutide, marketed in the U.S. as Saxenda, in 2014. However, the ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.

With Novo Nordisk’s patent on semaglutide set to expire in India, Dr Reddy’s is among the forerunners trying to bring the ...

Ozempic is making its presence known on menus, and the forecast for dumplings is 100% sunshine.

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

Novo said supply of Wegovy and Ozempic is in good shape after the drugs were removed from the FDA’s shortage list last week.

Smoothie King, the world's largest smoothie brand, is venturing into new territory with the launch of its "GLP-1 Support Menu," designed for individuals using GLP-1 agonists in their weight loss or ...

"Oral GLP-1 receptor agonist Rybelsus reduces risk of cardiovascular events in type 2 diabetes patients" was originally ...

It’s sold under the brand name Wegovy® and is produced ... Demand for Ozempic and other GLP-1 receptor agonist medications has soared recently due to their effectiveness for weight loss.

One big idea has loomed over healthcare stocks over the past two years: Demand for the new GLP-1 weight loss medicines from ...